Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
GALT
#3040
Galectin Therapeutics Inc.
2.9
8
-1.32%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-1.32%
Mudança mensal
-5.40%
Mudança em 6 meses
-25.87%
Mudança anual
+104.11%
Fechamento anterior
3.0
2
Open
2.9
8
Bid
Ask
Low
2.9
8
High
2.9
8
Volume
21
Mercados
Ações
Cuidados de saúde
GALT
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
8.58 M
12.8 M
7.7 M
6.6 M
3.5 M
30.6 M
Cash from investing activities
—
—
—
—
—
—
Cash from financing activities
10 M
851 K
0
12.94 M
1.3 M
15.09 M
Free cash flow
8.58 M
12.8 M
7.7 M
6.6 M
3.5 M
30.6 M
Notícias
Analyse von InvestingPro: Fair-Value-Modell prognostizierte 46 % Kursverlust bei PHPN/n
Galectin Therapeutics director Marc Rubin resigns from board
Fair-Value-Modell von InvestingPro prognostizierte Kurssturz von PHPN um 39 %
CFO von Galectin Therapeutics veräußert Aktien im Wert von 233.000 $
Galectin Therapeutics CFO sells $233k in shares
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
Insiderkauf bei Galectin Therapeutics: Director Kevin Freeman stockt Anteil nach Kurssturz auf
Insiderkauf bei Galectin: Director Freeman kauft nach Kurssturz zu
Insiderkauf bei Galectin Therapeutics: Director nutzt Kursrückgang
Galectin Therapeutics: Direktor kauft Aktien nach deutlichem Kursrückgang
Galectin Therapeutics: Director kauft Aktien nach deutlichem Kursrückgang
oracle, micron tech among market cap stock movers on friday